Pancreatic Cancer Research

ResearcherNagoya City UniversityNo recent work listed

Yuichi Hayashi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5279-332X; OpenAlex author ID A5030551274. Sources: OpenAlex.

Their work

Papers
7
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2019: 2 papers · 2020: none · 2021: 1 paper · 2022: 2 papers · 2023: 2 papers

Papers 7

  1. Upregulation of integrin‑linked kinase enhances tumor progression in gemcitabine‑resistant pancreatic cancer. Co-author DOI 10.3892/or.2023.8601↗
  2. Girdin regulates both migration and angiogenesis in pancreatic cancer cell lines. Co-author DOI 10.3892/or.2023.8606↗
  3. 10Z‑Hymenialdisine inhibits angiogenesis by suppressing NF‑κB activation in pancreatic cancer cell lines. Co-author DOI 10.3892/or.2022.8259↗
  4. Enhanced CXCL12/CXCR4 signaling increases tumor progression in radiation‑resistant pancreatic cancer. Co-author DOI 10.3892/or.2022.8279↗
  5. Escin inhibits angiogenesis by suppressing interleukin‑8 and vascular endothelial growth factor production by blocking nuclear factor‑κB activation in pancreat… Co-author DOI 10.3892/or.2021.8006↗
  6. Acquisition of gemcitabine resistance enhances angiogenesis via upregulation of IL‑8 production in pancreatic cancer. Co-author DOI 10.3892/or.2019.7105↗
  7. [A Case of Conversion Surgery for an Initially Locally Advanced Unresectable Pancreatic Cancer after S-1 Chemotherapy]. Co-author PMID 32156996↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hiroyuki Imafuji · 7 shared papers, 2019–2023 · strength 0.85
  2. Yoichi Matsuo · 7 shared papers, 2019–2023 · strength 0.85
  3. Shuji Takiguchi · 7 shared papers, 2019–2023 · strength 0.85
  4. Mamoru Morimoto · 7 shared papers, 2019–2023 · strength 0.85
  5. Hiroki Takahashi · 7 shared papers, 2019–2023 · strength 0.85
  6. Kenta Saito · 7 shared papers, 2019–2023 · strength 0.85
  7. Kan Omi · 6 shared papers, 2019–2023 · strength 0.70
  8. Goro Ueda · 6 shared papers, 2019–2023 · strength 0.70
  9. Tomokatsu Kato · 5 shared papers, 2021–2023 · strength 0.68
  10. Hiromichi Murase · 4 shared papers, 2022–2023 · strength 0.57
  11. Keisuke Nonoyama · 2 shared papers, 2023 · strength 0.30
  12. Yuki Denda · 2 shared papers, 2023 · strength 0.30

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.